Cambridge researchers test first human vaccine designed entirely by artificial intelligence
By
James Gallagher
Summary
Researchers at the University of Cambridge have developed what they describe as a 'world-first' vaccine whose key component was designed entirely by artificial intelligence and then trialled in humans. The vaccine targets all coronaviruses, including all COVID-19 variants and animal viruses with pandemic potential. This marks the first time an AI-designed vaccine component has reached human trials, representing a significant milestone in vaccine development and pandemic preparedness.
Source
Key quotes
· 3 pulledArtificial intelligence has been used to develop a 'fundamentally new' type of vaccine that could protect against large swathes of viruses and prevent pandemics, say researchers.
The team at the University of Cambridge say it is the first time a vaccine's key component has been designed entirely by AI and then trialled in people.
The vaccine was engineered to work on all coronaviruses which would include all Covid variants as well as viruses that currently infect animals yet have the potential to start the next pandemic.
You might also wanna read
Why COVID-19 vaccines were developed in record time: funding, prior research, and parallel processes
This article explains why COVID-19 vaccines were developed in record time — roughly 11 months — compared to the typical 8-12 year vaccine ti
Why COVID-19 vaccines were developed in record time: funding, prior research, and parallel processes
This article explains why COVID-19 vaccines were developed in record time — roughly 11 months — compared to the typical 8-12 year vaccine ti
Stanford Researchers Develop Nasal Spray Vaccine for Universal Protection Against Respiratory Illnesses
Stanford University researchers have developed a nasal spray vaccine that could provide universal protection against all coughs, colds, flus
Stanford Researchers Develop Universal Vaccine Formula Protecting Mice Against Respiratory Viruses, Bacteria, and Allergens
Stanford Medicine researchers have developed a universal vaccine formula that protects mice against a wide range of respiratory viruses, bac
The AI Adaptation Challenge: Lessons from the Pandemic's Early Days
The author draws a parallel between the early days of the COVID-19 pandemic (March 2020 in Helsinki) and the current state of AI development
Scientists Develop Universal Cancer Vaccine Using mRNA Technology
Scientists have developed a 'universal cancer vaccine' using mRNA technology that can train the immune system to target any type of cancer,

AI Safety Researchers at Anthropic Work to Prevent Potential Societal Harms from Advanced AI Systems
The article focuses on Deep Ganguli, a research director at Stanford Institute for Human-Centered AI, who became concerned about the rapid a

Comments
Sign in to join the conversation.
No comments yet. Be the first.